title: No long-term benefit of low-dose OKT3 induction therapy in non to moderately immunized renal allograft recipients.
authors.affiliation: Department of Nephrology, Academic Medical Centre, Amsterdam, The Netherlands.
authors.forename: F J
authors.initials: FJ
authors.lastname: Bemelman
authors.forename: S
authors.initials: S
authors.lastname: Yong
authors.forename: K J
authors.initials: KJ
authors.lastname: Parlevliet
authors.forename: S
authors.initials: S
authors.lastname: Surachno
authors.forename: P T A
authors.initials: PT
authors.lastname: Schellekens
authors.forename: R J M
authors.initials: RJ
authors.lastname: ten Berge
mesh_terms: D000328:Adult; D016572:Cyclosporine / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D006085:Graft Survival / Q000276:immunology; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007518:Isoantibodies / Q000097:blood; D016030:Kidney Transplantation / Q000276:immunology* / Q000401:mortality; D016853:Muromonab-CD3 / Q000627:therapeutic use*; D018579:Patient Selection; D011241:Prednisone / Q000627:therapeutic use; D016019:Survival Analysis; D013997:Time Factors; D014184:Transplantation, Homologous / Q000276:immunology
chemical_list: D007166:Immunosuppressive Agents; D007518:Isoantibodies; D016853:Muromonab-CD3; D016572:Cyclosporine; D011241:Prednisone